We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | 2.95 | -1.93 | NA | -7.86 | 0 | |
| NOVARTIS INDIA LTD. | 997.30 | 242.20 | 903.30 | 9.81 | 2,162 | 21.0 |
| AMRUTANJAN HEALTH CARE LTD. | 1,219.97 | 139.62 | 1,177.00 | 4.83 | 2097 | 103.0 |
| Windlas Biotech Limited | 2,260.43 | 178.00 | 2,223.98 | 8.40 | 1945 | 29.8 |
Novartis India Limited., with Security Code 500672, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 84.5 | 81.2 | 92.3 | 87.1 | 93.0 | 83.9 | 87.6 | 90.3 |
| Expenses | 64.8 | 70.0 | 68.3 | 69.1 | 67.4 | 60.0 | 60.3 | 66.5 |
| Operating Profit | 19.8 | 11.2 | 24.0 | 18.0 | 25.6 | 23.9 | 27.2 | 23.9 |
| OPM % | 23.39% | 13.81% | 25.96% | 20.62% | 27.51% | 28.51% | 31.11% | 26.44% |
| Other Income | 22.0 | 10.4 | 10.4 | 10.3 | 10.6 | 10.6 | 10.6 | 9.4 |
| Interest | 0.2 | 0.2 | 0.2 | 0.1 | 0.4 | 0.1 | 0.1 | 0.1 |
| Depreciation | 0.3 | 0.1 | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 |
| Profit before tax | 41.3 | 21.3 | 33.7 | 27.6 | 35.3 | 33.9 | 37.2 | 32.7 |
| Tax % | -35.7% | -31.2% | -23.6% | -25.9% | -27.9% | -13.5% | -25.8% | -25.8% |
| Net Profit | 26.6 | 14.7 | 25.7 | 20.4 | 25.5 | 29.3 | 27.6 | 24.2 |
| EPS in Rs | 10.76 | 5.95 | 10.42 | 8.27 | 10.31 | 0 | 0 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | -4% |
| 3 Years: | -4% |
| TTM: | 6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 58% |
| 3 Years: | 35% |
| TTM: | 21% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 11% |
| 3 Years: | 18% |
| 1 Year: | -14% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|